| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-15 |
4 |
AS |
$170.06 |
$5,952,100 |
D/D |
(35,000) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-04 |
4 |
GA |
$0.00 |
$0 |
D/D |
28,124 |
1,029,793 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
109,475 |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-27 |
5 |
GA |
$0.00 |
$0 |
D/D |
480 |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-13 |
5 |
GA |
$0.00 |
$0 |
D/D |
9,726 |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-18 |
4 |
AS |
$123.35 |
$17,569,149 |
D/D |
(140,000) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-19 |
4 |
AS |
$129.90 |
$4,546,500 |
D/D |
(35,000) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-08 |
4 |
AS |
$134.93 |
$865,036 |
D/D |
(6,411) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-09 |
4 |
AS |
$135.05 |
$140,317 |
D/D |
(1,039) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-10 |
4 |
AS |
$135.00 |
$1,580,175 |
D/D |
(11,705) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,100 |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-28 |
4 |
AS |
$155.12 |
$587,905 |
D/D |
(3,790) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-29 |
4 |
AS |
$155.31 |
$10,346,256 |
D/D |
(66,210) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-20 |
4 |
AS |
$155.60 |
$10,917,528 |
D/D |
(70,000) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-27 |
4 |
AS |
$165.52 |
$11,631,349 |
D/D |
(70,000) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-06-20 |
4 |
AS |
$159.96 |
$14,770,187 |
D/D |
(90,280) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-09 |
4 |
OE |
$6.90 |
$7,169 |
D/D |
1,039 |
1,032,996 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-10 |
4 |
A |
$17.98 |
$219,338 |
D/D |
12,199 |
1,033,473 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-30 |
4 |
AS |
$109.92 |
$54,960 |
D/D |
(500) |
1,034,177 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-29 |
4 |
AS |
$109.93 |
$218,981 |
D/D |
(1,992) |
1,034,677 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-28 |
4 |
OE |
$10.29 |
$38,999 |
D/D |
3,790 |
1,036,121 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-16 |
4 |
AS |
$104.97 |
$5,740,924 |
D/D |
(54,548) |
1,036,669 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-08 |
4 |
OE |
$5.18 |
$34,776 |
D/D |
6,411 |
1,038,368 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-08 |
4 |
OE |
$17.98 |
$381,428 |
D/D |
21,214 |
1,042,488 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-10 |
4 |
OE |
$6.90 |
$80,765 |
D/D |
11,705 |
1,043,662 |
0 |
- |
|
283 Records found
|
|
Page 9 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
